Representative Bruce Westerman (R-Arkansas) recently sold shares of Intuitive Surgical, Inc. (NASDAQ:ISRG). In a filing disclosed on May 12th, the Representative disclosed that they had sold between $1,001 and $15,000 in Intuitive Surgical stock on April 21st. The trade occurred in the Representative’s “FISHER IRA” account.
Representative Bruce Westerman also recently made the following trade(s):
- Sold $1,001 – $15,000 in shares of UniCredit (OTCMKTS:UNCRY) on 4/21/2025.
- Sold $1,001 – $15,000 in shares of CSX (NASDAQ:CSX) on 4/21/2025.
- Sold $1,001 – $15,000 in shares of Siemens Aktiengesellschaft (OTCMKTS:SIEGY) on 4/21/2025.
- Sold $1,001 – $15,000 in shares of GSK (NYSE:GSK) on 4/21/2025.
- Sold $1,001 – $15,000 in shares of Charles Schwab (NYSE:SCHW) on 4/21/2025.
- Sold $1,001 – $15,000 in shares of The Goldman Sachs Group (NYSE:GS) on 4/21/2025.
- Sold $1,001 – $15,000 in shares of Abbott Laboratories (NYSE:ABT) on 4/21/2025.
- Sold $1,001 – $15,000 in shares of Eli Lilly and Company (NYSE:LLY) on 4/21/2025.
- Sold $15,001 – $50,000 in shares of NVIDIA (NASDAQ:NVDA) on 4/21/2025.
- Sold $1,001 – $15,000 in shares of Chevron (NYSE:CVX) on 4/21/2025.
Intuitive Surgical Stock Performance
NASDAQ ISRG opened at $563.95 on Wednesday. The stock has a market capitalization of $202.13 billion, a P/E ratio of 87.98, a price-to-earnings-growth ratio of 5.85 and a beta of 1.70. Intuitive Surgical, Inc. has a 52 week low of $379.67 and a 52 week high of $616.00. The stock has a fifty day moving average of $501.31 and a 200-day moving average of $535.58.
Insider Buying and Selling
In other Intuitive Surgical news, VP Fredrik Widman sold 810 shares of the company’s stock in a transaction that occurred on Monday, March 3rd. The stock was sold at an average price of $573.78, for a total transaction of $464,761.80. Following the completion of the transaction, the vice president now owns 473 shares of the company’s stock, valued at $271,397.94. This represents a 63.13% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, EVP Robert Desantis sold 11,545 shares of Intuitive Surgical stock in a transaction that occurred on Thursday, March 13th. The shares were sold at an average price of $499.22, for a total transaction of $5,763,494.90. Following the completion of the sale, the executive vice president now owns 5,224 shares in the company, valued at $2,607,925.28. This trade represents a 68.85% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders sold 32,636 shares of company stock worth $16,829,815. 0.70% of the stock is owned by corporate insiders.
Institutional Trading of Intuitive Surgical
Hedge funds have recently bought and sold shares of the stock. Vanguard Group Inc. lifted its position in Intuitive Surgical by 1.4% in the 1st quarter. Vanguard Group Inc. now owns 32,665,531 shares of the medical equipment provider’s stock valued at $16,178,258,000 after acquiring an additional 453,335 shares in the last quarter. Geode Capital Management LLC raised its stake in shares of Intuitive Surgical by 3.2% in the 4th quarter. Geode Capital Management LLC now owns 7,756,727 shares of the medical equipment provider’s stock valued at $4,039,200,000 after purchasing an additional 243,802 shares during the period. Fisher Asset Management LLC lifted its holdings in shares of Intuitive Surgical by 1.8% in the fourth quarter. Fisher Asset Management LLC now owns 4,868,869 shares of the medical equipment provider’s stock valued at $2,541,356,000 after purchasing an additional 86,488 shares in the last quarter. Norges Bank acquired a new position in shares of Intuitive Surgical during the fourth quarter worth about $2,401,493,000. Finally, Invesco Ltd. boosted its position in shares of Intuitive Surgical by 1.7% during the first quarter. Invesco Ltd. now owns 4,219,974 shares of the medical equipment provider’s stock worth $2,090,027,000 after buying an additional 71,794 shares during the period. 83.64% of the stock is currently owned by institutional investors and hedge funds.
Analysts Set New Price Targets
A number of equities research analysts recently weighed in on the stock. Jefferies Financial Group boosted their price target on shares of Intuitive Surgical from $475.00 to $575.00 in a research note on Monday, January 27th. Leerink Partners upped their target price on shares of Intuitive Surgical from $490.00 to $548.00 in a research report on Monday, January 27th. Truist Financial cut their price target on Intuitive Surgical from $605.00 to $590.00 and set a “buy” rating on the stock in a research note on Wednesday, April 23rd. CICC Research started coverage on Intuitive Surgical in a research note on Monday, January 27th. They set a “neutral” rating and a $550.00 price objective for the company. Finally, Raymond James upped their price objective on Intuitive Surgical from $560.00 to $688.00 and gave the company an “outperform” rating in a report on Friday, January 24th. Five investment analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $598.95.
Read Our Latest Stock Analysis on Intuitive Surgical
About Representative Westerman
Bruce Westerman (Republican Party) is a member of the U.S. House, representing Arkansas’ 4th Congressional District. He assumed office on January 3, 2015. His current term ends on January 3, 2027.
Westerman (Republican Party) is running for re-election to the U.S. House to represent Arkansas’ 4th Congressional District. He declared candidacy for the 2026 election.
Westerman earned his BSBAGE in biological and agricultural engineering from the University of Arkansas in 1990 and his MF in forestry from Yale University in 2001. His professional experience includes working as a plant engineer for Riceland Foods and an engineer/forester for Mid-South Engineering Company.
Intuitive Surgical Company Profile
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
See Also
- Five stocks we like better than Intuitive Surgical
- How to trade penny stocks: A step-by-step guide
- U.S. Regulators Target CrowdStrike: Is It a Signal or Noise?
- 3 Small Caps With Big Return Potential
- 3 AI ETFs Tapping Into the Heart of the AI Revolution
- How to Know Which Cryptocurrency to Buy: A Guide for Investors
- Archer Posts Surprise Q1 Beat, Sets Stage for 2025 Revenue Launch
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.